Chronic open-angle glaucoma and lifestyle

Progress in Retinal and Eye Research

Volumn 16, Issue 4, 1997, Pages 567-590

  Stewart, William C ^a,b  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; MIOTIC AGENT;

ALCOHOL CONSUMPTION; APNEA; ARTICLE; BLOOD DYSCRASIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CIGARETTE SMOKING; CONJUNCTIVA DISEASE; DRUG FATALITY; DRY EYE; DYSPNEA; ELECTROLYTE DISTURBANCE; EMOTION; ERYTHEMA; GASTROINTESTINAL SYMPTOM; HYPEREMIA; INTRAOCULAR PRESSURE; ISOTONIC EXERCISE; LIFESTYLE; LUNG DISEASE; MIOSIS; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; UROGENITAL TRACT DISEASE; VISUAL IMPAIRMENT;

EID: 0030816772     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(96)00040-7     Document Type: Review

References (168)

1. Abrams, D. A., Robin, A. L., Pollack, I. P., deFaller, J. M. and DeSantis, L. (1987) The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers. Arch. Ophthalmol. 105: 1205-1207.
2. Adams, B. A. and Brubaker, R. F. (1990) Caffeine has no clinically significant effect on aqueous humor flow in the normal human eye. Ophthalmology 97: 1030-1031.
3. Allen, C., Stetz, D., Roman, S. H., Podos, S., Som, P. and Davies, T. F. (1985) Prevalence and clinical associations of intraocular pressure changes in Graves' disease. J. clin. Endocr. Metab. 61: 183-187.
4. Alm, A., Stjernschantz, J. and Scandinavian Latanoprost Study Group (1994) Effects on IOP and side-effects of 0.005% latanoprost once daily, evening or morning: a comparison with timolol. Presented at the American Academy of Ophthalmology, San Francisco, California.
5. Anderson, D. R. and Grant, W. M. (1973) The influence of position on intraocular pressure. Invest. Ophthalmol. 12: 204-212.
6. Andreoli, T. E., Bennett, J. C., Carpenter, C. C. J., Plum, F. and Smith, L. H., eds (1993) Hypertension and vascular disorders of the kidney. In: Cecil Essentials of Medicine, 3rd edn, pp. 230-237. WB Saunders, Philadelphia.
7. Ashkenazi, I., Melamed, S. and Blumenthal, M. (1992) The effect of continuous strenuous exercise on intraocular pressure. Invest. Ophthalmol. Vis. Sci. 33: 2874-2877.
8. Atkins, J. M. (1989) Effects of topical beta blockers on cardiovascular function during exercise. Int. Ophthalmol. Clin. 29, (Suppl.): S23.
9. Avorn, J., Glynn, R. J., Gurwitz, J. H., Bohn, R. L., Monane, M., Everitt, D. E., Gilden, D. and Choodnovskiy, I. (1993) Adverse pulmonary effects of topical beta blockers used in the treatment of glaucoma. J. Glaucoma 2: 158-165.
10. Bain, W. E. S. and Maurice, D. M. (1959) Physiological variations in the intraocular pressure. Trans Ophthalmol. Soc. UK 79: 249-255.
11. Bankes, J. L. K. (1967) Ocular tension and diabetes mellitus. Br. J. Ophthalmol. 51: 557-561.
12. Becker, B. (1971) Diabetes mellitus and primary open-angle glaucoma. Am. J. Ophthalmol. 71: 1-14.
13. Bengtsson, B. (1980) Findings associated with glaucomatous visual field defects. Acta Ophthalmol. Copenh. 58: 20-32.
14. Biró, I. and Botar, Z. (1962) On the beavior of intraocular tension in various sport acticities. Klin. Monatsbl. Augenheilkd. 140: 23-30.
15. Björnsson, G. (1967) The primary glaucoma in Iceland: Epidemiological studies. Acta Ophthalmol. Copenh. 91: 1-99.
16. Blackwell, B. (1973) Patient compliance. N. Engl. J. Med. 289: 249-252.
17. Bloch, S., Rosenthal, R., Friedman, L. and Caldarolla, P. (1977) Patient compliance in glaucoma. Br. J. Ophthalmol. 61: 531-534.
18. Block, E. R. and Rostand, R. A. (1978) Carbonic anhydrase inhibition in glaucoma: Hazard or benefit for the chronic lunger?. Surv. Ophthalmol. 23: 169-172.
19. Booth, F. M., Saad, R. and Tait, S. A. (1991) Tonography, Valsalva manoeuvre, and central visual fields: a study of 429 patients. Aust. NZ J. Ophthalmol. 19: 53-59.
20. Botet, C., Grau, J., Benito, P., Coll, J. and Vivancos, J. (1986) Timolol ophthalmic solution and respiratory arrest. Arch. Int. Med. 105: 306-307.
21. Bouzas, A. G., Gragoudas, E. S., Balodimos, M. C., Brinegar, C. H. and Aiello, L. M. (1971) Intraocular pressure in diabetes: Relationship to retinopathy and blood glucose level. Arch. Ophthalmol. 85: 423-427.
22. Bovino, J. A. and Marcus, D. F. (1982) The mechanism of transient myopia induced by sulfonamide therapy. Am. J. Ophthalmol. 94: 99-102.
23. Burnstine, R. A., Felton, J. L. and Ginther, W. H. (1982) Cardiorespiratory reaction to timolol maleate in a pediatric patient: A case report. Ann. Ophthalmol. 14: 905-906.
24. Buschmann, W. (1986) Glaucoma and Graves' disease. Klin. Monatsbl. Augenheilkd. 188: 138-140.
25. Camras, C. B., Wax, M., Ritch, R., Weinreb, R. N., Robin, A. L., Higgenbothem, E. J. and USA Latanoprst Study Group (1994) Latanoprost. A potent ocular hypotensive prostaglandin analog, increases pigmentation in peripherally hypopigmented irides. Presented at the American Academy of Ophthalmology, San Francisco, California.
26. Carel, R. S., Korczyn, A. D., Rock, M. and Goya, I. (1984) Association between ocular pressure and certain health parameters. Ophthalmology 91: 311-314.
27. Carlson, K. H., McLaren, J. W., Topper, J. E. and Brubaker, R. F. (1987) Effect of body position on intraocular pressure and aqueous flow. Invest. Ophthalmol. Vis. Sci. 28: 1346-1352.
28. Charap, A. D., Shin, D. H., Petursson, G., Cinotti, D., Wortham, E., Brown, R. H., Silverstone, D. E., Atkins, J, M., Eto, C. Y., Lue, J. C. and Novack, G. D. (1989) Effect of varying drop size on the efficacy and safety of a topical beta blocker. Ann. Ophthalmol. 21: 351-357.
29. Coleman, D. J. and Trokel, S. (1969) Direct-recorded intraocular pressure variations in a human subject. Arch. Ophthalmol. 82: 637-640.
30. Coleman, A. L., Diehl, D. L. C., Jampel, H. D., Bachorik, P. S. and Quigley, H. A. (1990a) Topical timolol decreases plasma high-density lipoprotein cholesterol level. Arch. Ophthalmol. 108: 1260-1263.
31. Coleman, A. L., Robin, A. L., Pollack, I. P., Rudikoff, M. T., Enger, C. and Mayer, P. R. (1990b) Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine. Arch. Ophthalmol. 108: 1264-1267.
32. Constant, M. A. and Becker, B. (1960) The effect of carbonic anhydrase inhibitors on urinary excretion of citrate by humans. Am. J. Ophthalmol. 49: 929.
33. Coyle, J. T. (1983) Timoptic and depression. J. Ocular Ther. Surg. Nov-Dec: 311.
34. Critchlow, A. S., Freeborn, S. F. and Roddie, R. A. (1984) Potassium supplements during treatment of glaucoma with acetazolamide. Br. Med. J. 289: 21.
35. Dalton, K. (1967) Influence of menstruation on glaucoma. Br. J. Ophthalmol. 51: 692-695.
36. Derick, R. J., Walters, T. R., Robin, A. L., Barnebey, H. S., Choplin, N. T., Kelley, E. P. and Stoecker, J. F. (1993) Brimonidine tartrate: a one month dose response study. Invest. Ophthalmol. Vis. Sci. Suppl. 34: 1138.
37. Diggory, P., Heyworth, P., Chau, G., McKenzie, S. and Sharma, A. (1994) Unsuspected bronchospasm in association with topical timolol - a common problem in elderly people: can we easily identify those affected and do cardioselective agents lead to improvement? Age and Aging 23: 17-21.
38. Dinai, Y., Sharir, M., Naveh, N. and Halkin, H. (1985) Bradycardia induced by interaction between quinidine and ophthalmic timolol. Ann. Int. Med. 103: 890-891.
39. Doyle, W. J., Weber, P. A. and Meeks, R. H. (1984) Effect of topical timolol maleate on exercise performance. Arch. Ophthalmol. 102: 1517-1518.
40. Dreyer, E. B. (1993) Inhaled steroid use and glaucoma. N. Engl. J. Med. 329: 1822.
41. Eichhorn, E. J. (1994) Do beta-blockers have a role in patients with congestive heart failure? Cardiol. Clin. 12: 133-142.
42. Epstein, H. M., Fagman, W., Bruce, D. L. and Abram, A. (1975) Intraocular pressure changes during anesthesia for electroshock therapy. Anesth. Analg. 54: 479-481.
43. Epstein, D. L. and Grant, W. M. (1977) Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch. Ophthalmol. 95: 1378-1382.
44. Epstein, R. J., Allen, R. C. and Lunde, M. W. (1987) Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma. Ann. Ophthalmol. 19: 48-50.
45. Era, P., Pärssinen, O., Kallinen, M. and Suominen, H. (1993) Effect of bicycle ergometer test on intraocular pressure in elderly athletes and controls. Acta Ophthalmol. Copenh. 71: 301-307.
46. Fraunfelder, F. T. and Meyer, S. M. (1985) Sexual dysfunction secondary to topical ophthalmic timolol. J. Am. Med. Assoc. 253: 3092-3093.
47. Fraunfelder, F. T., Meyer, S. M., Bagby, G. C. and Dreis, M. W. (1985a) Hematologic reactions to carbonic anhydrase inhibitors. Am. J. Ophthalmol. 100: 79-81.
48. Fraunfelder, F. T., Meyer, S. M. and Bagby, G. C. (1985b) Reply to letter 'Hematologic reactions to carbonic anhydrase inhibitors'. Am. J. Ophthalmol. 100: 746.
49. Fraunfelder, F. T. and Meyer, S. M. (1989) Systemic adverse reactions to glaucoma medications. Int. Ophthalmol. Clin. 29: 143-146.
50. Freedman, S. F., Freedman, N. J., Shields, M. B., Lobaugh, B., Samsa, G. P., Keates, E. U. and Ollie, A. (1993) Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am. J. Ophthalmol. 116: 600-611.
51. Friberg, T. R., Sanborn, G. and Weinreb, R. N. (1987) Intraocular and episderal venous pressure increase during inverted posture. Am. J. Ophthalmol. 103: 523-526.
52. Glynn, R. J., Seddon, J. M., Krug, J. H., Sahigian, C. R., Chiavelli, M. E. and Campion, E. W. (1991) Falls in elderly patients with glaucoma. Arch. Ophthalmol. 109: 205-210.
53. Goodman, L. S. and Gilman, A. (eds) (1970) The Pharmacological Basis of Therapeutics. The MacMillan Co., Toronto, Canada.
54. Graber, M. and Kelleher, S. (1988) Side effects of acetazolamide: The champagne blues. Am. J. Med. 84: 979-980.
55. Grant, W. M. (1972) Antiglaucoma drugs: problems with carbonic anhydrase inhibitors. In: Symposium on Ocular Therapy (I. H. Leopold, ed.). CV Mosby, St Louis, MO.
56. Greco, J. J. and Kelman, C. D. (1973) Systemic pilocarpine toxicity in the treatment of angle closure glaucoma. Ann. Ophthalmol. 5: 57-59.
57. Green, K. (1975) Ocular effects of diacetyl morphine and lysergic acid diethylamide in rabbit. Invest. Ophthalmol. 14: 325-329.
58. Green, K., Cullen, P. M. and Phillips, C. I. (1984) Aqueous humour turnover and intraocular pressure during menstruation. Br. J. Ophthalmol. 68: 736-740.
59. 1-tetrahydrocannabinol on aqueous dynamics and ciliary body permeability in the rabbit. Exp. Eye Res. 15: 499-507.
60. Havener, W. H. (1983) Ocular Pharmacology. CV Mosby, St. Louis, MO.
61. Heller, I., Halevy, J., Cohen, S. and Theodor, E. (1985) Significant metabolic acidosis induced by acetazolamide. Not a rare complication. Arch. Int. Med. 145: 1815-1817.
62. Hepler, R. S. and Frank, I. R. (1971) Marihuana smoking and intraocular pressure. J. Am. Med. Assoc. 271: 1392.
63. Higginbotham, E. J. (1996) Topical beta-adrenergic antagonists and quinidine. Arch. Ophthalmol. 114: 745-746.
64. Higginbotham, E. J., Kilimanjaro, H. A., Wilensky, J. T., Batenhorst, R. L. and Hermann, D. (1989) The effect of caffeine on intraocular pressure in glaucoma patients. Ophthalmology 96: 624-626.
65. Houle, R. E. and Grant, W. M. (1967) Alcohol, vasopressin, and intraocular pressure. Invest. Ophthalmol. 6: 145-154.
66. Jampel, H. D., Robin, A. L., Quigley, H. A. and Pollack, I. P. (1992) Apraclonidine. A one-week dose-response. Apraclonidine reduces intraocular pressure in eyes with increased episcleral venous pressure. J. Glaucoma 1: 42-43.
67. Johnson, T. D. and Zimmerman, T. J. (1986) Ocular hypertension, glaucoma suspect, preglaucoma, or glaucoma? Synopsis of views. Ann. Ophthalmol. 18: 313-314.
68. Kahn, H. A., Leibowitz, H. M., Ganley, J. P., Kini, M. M., Colton, T., Nickerson, R. S. and Dawber, T. R. (1977) The Framingham Eye Study: II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am. J. Epidemiol. 106: 33-41.
69. Kahn, H. A., Roy, M. A. and Milton, C. (1980) Alternative definitions of open-angle glaucoma. Arch. Ophthalmol. 98: 2172-2177.
70. Kass, M. A. (1983) When to treat ocular hypertension. Surv. Ophthalmol. 28, Suppl.: 229-232.
71. Kass, M. A. and Sears, M. L. (1977) Hormonal regulation of intraocular pressure. Surv. Ophthalmol. 22: 153-176.
72. Katz, J. and Sommer, A. (1988) Risk factors for primary open angle glaucoma. Am. J. Prev. Med. 4: 110-114.
73. Keltner, J. L. and Johnson, C. A. (1987) Visual function, driving safety and the elderly. Ophthalmology 94: 1180-1188.
74. Kitazawa, Y. (1993) Multicenter double-blind comparison of carteolol and timolol in primary open-angle glaucoma and ocular hypertension. Adv. Ther. 10: 95-131.
75. Klein, B. E. K., Klein, R. and Ritter, L. L. (1993) Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma: The Beaver Dam Eye Study. Ophthalmology 100: 1609-1613.
76. Koella, W. P. (1985) CNS-related (side-)effects of β-blockers with special reference to mechanisms of action. Eur. J. clin. Pharmacol. 28, suppl: 55-63.
77. Kreiglstein, G. K., Brethfeld, V. and von Collani, E. (1976) Comparative intraocular pressure measurements with position independent hand-application tonometers. Graefes Arch. clin. exp. Ophthalmol. 199: 101-113.
78. Lanigan, L. P., Clark, C. V. and Hill, D. W. (1989) Intraocular pressure responses to systemic autonomie stimulation. Eye 3: 477-483.
79. Laursen, S. O. and Bjerrum, P. (1982) Timolol eyedrop-induced severe bronchospasm. Acta Med. Scand. 211: 505-506.
80. Lazenby, G. W., Reed, J. W. and Grant, W. M. (1970) Anticholinergic medication in open-angle glaucoma. Arch. Ophthalmol. 84: 719.
81. Leier, C. V., Baker, N. D. and Weber, P. A. (1986) Cardiovascular effects of ophthalmic timolol. Ann. Int. Med. 104: 197-199.
82. Lempert, P., Cooper, K. H., Culver, J. F. and Tredici, T. J. (1967) The effect of exercise on intraocular pressure. Am. J. Ophthalmol. 63: 1673-1676.
83. Leonard, T. J. K., Kerr Muir, M. G., Kirkby, G. R. and Hitchings, R. A. (1983) Ocular hypertension and posture. Br. J. Ophthalmol. 67: 362-366.
84. Leske, M. C. and Podgor, M. J. (1983) Intraocular pressure, cardiovascular risk variables, and visual field defects. Am. J. Epidemiol. 118: 280-287.
85. Leske, M. C. and Rosenthal, J. (1979) Epidemiologic aspects of open-angle glaucoma. Am. J. Epidemiol. 109: 250-272.
86. Lichter, P. R. (1981) Reducing side effects of carbonic anhydrase inhibitors. Ophthalmology 88: 266-269.
87. Lichter, P. R. (1988) Carbonic anhydrase inhibitors, blood dyscrasias, and standard-of-care. Ophthalmology 95: 711-712.
88. Lichter, P. R. (1990) Caffeine and other prescriptions for patients with glaucoma. Ophthalmology 97: 965-966.
89. Löfdahl, C.-G. (1982) Selectivity of β-adrenoceptor agonists and antagonists in asthmatics. Eur. J. Respir. Dis. 63, Suppl. 120: 1-53.
90. Löfdahl, C.-G. (1989) Antihypertensive drugs and airway function, with special reference to calcium channel blockade. J. Cardiovasc. Pharmacol. 14: S40-S51.
91. Lustgarten, J. S. (1988) Topical timolol-induced arthropathy. Am. J. Ophthalmol. 105: 687-688.
92. Lyons, D. E. (1971) Postural changes in IOP in dysthyroid exophthalmos. Trans. Ophthalmol. Soc. UK 91: 799-803.
93. Macri, F. J, and Brubaker, R. F. (1969) Methodology of eye pressure measurement. Biorheology 6: 37-45.
94. McCoy, G. C., Blanchard, E. B., Wittrock, D. A., Morrison, S., Pangburn, L., Siracusa, K. and Pallmeyer, T. P. (1988) Biochemical changes associated with thermal biofeedback treatment of hypertension. Biofeedback Self-Regul. 13: 139-150.
95. McLeod, S. D., West, S. K., Quigley, H. A. and Fozard, J. L. (1990) A longitudinal study of the relationship between intraocular and blood pressures. Invest. Ophthalmol. Vis. Sci. 31: 2361-2366.
96. McMahon, C. D., Schaffer, R. N., Hoskins, H. D. and Hetherington, J. (1979) Adverse effects experienced by patients taking timolol. Am. J. Ophthalmol. 88: 736-738.
97. McNeill, R. S. (1964) Effect of a beta-adrenergic-blocking agent, propranolol, on asthmatics. The Lancet 2: 1101-1102.
98. Maren, T. H. (1986) Acetazolamide and advanced liver disease. Am. J. Ophthalmol. 102: 672-673.
99. Maren, T. H., Haywood, J. R., Chapman, S. K. and Zimmerman, T. J. (1977) The pharmacology of the methazolamide in relation to the treatment of glaucoma. Invest. Ophthalmol. Vis. Sci. 16: 730-742.
100. Margo, C. E. (1986) Acetazolamide and advanced liver disease. Am. J. Ophthalmol. 101: 611-612.
101. Maus, T. L., Larsson, L.-I. and Brubaker, R. F. (1994) Ocular effects of scopolamine dermal patch in open-angle glaucoma. J. Glaucoma 3: 190-194.
102. Mehra, K. S., Roy, P. N. and Khare, B. B. (1976) Tobacco smoking and glaucoma. Ann. Ophthalmol. 8: 462-464.
103. Mogk, L. G. and Cyrlin, M. N. (1988) Blood dyscrasias and carbonic anhydrase inhibitors. Ophthalmology 95: 768-771.
104. Morgan, R. W. and Drance, S. M. (1975) Chronic open-angle glaucoma and ocular hypertension: An epidemiological study. Br. J. Ophthalmol. 59: 211-215.
105. Moses, R. A., Carniglia, P. E., Grodzki, W. J. and Moses, J. (1984) Proptosis and increase of intraocular pressure in voluntary lid fissure widening. Invest. Ophthalmol. Vis. Sci. 25: 989-992.
106. Moses, R. A., Lurie, P. and Wette, R. (1982) Horizontal gaze position effect on intraocular pressure. Invest. Ophthalmol. Vis. Sci. 22: 551-553.
107. Nardi, M., Bartolomei, M. P., Romani, A. and Barca, L. (1988) Intraocular pressure changes in secondary positions of gaze in normal subjects and in restrictive ocular motility disorers. Graefes Arch. clin. exp. Ophthalmol. 226: 8-10.
108. Nelson, W. L., Fraunfelder, F. T., Sills, J. M., Arrowsmith, J. B. and Kuritsky, J. N. (1986) Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am. J. Ophthalmol. 102: 606-611.
109. Neufeld, A. H. (1984) The mechanisms of action of adrenergic drugs in the eye. In: Glaucoma: Applied Pharmacology in Medical Treatment (S. M. Drance, A. H. Neufeld, eds). Grune and Stratton, Orlando, FL.
110. Nielsen, N. V. (1983) The prevalence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus: An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol. Copenh. 61: 662-672.
111. Nordlund, J. R., Pasquale, L. R., Robin, A. L., Rudikoff, M. T., Ordman, J., Chen, K. S. and Walt, J. (1995) The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% Brimonidine. Arch. Ophthalmol. 113: 77-83.
112. Oggel, K., Sommer, G., Neuhann, T. and Hinz, J. (1982) Veränderungen des augeninnendruckes bei intrathorakaler druckerhöhung in abhängigkeit von der körperposition und der achsenlänge des augapfels. Graefes Arch. clin. exp. Ophthalmol. 218: 51-54.
113. Olson, R. J., Bromberg, B. B. and Zimmerman, T. J. (1979) Apneic spells associated with timolol therapy in a neonate. Am. J. Ophthalmol. 88: 120-122.
114. Packer, H., Deutsch, A. R., Horsley, M. B. and Lewis, P. M. (1962) Glaucoma detection in Memphis. Tenn. Am. J. Publ. Hlth 52: 450-454.
115. Parsley, J., Powell, R. G., Keightley, S. J. and Elkington, A. R. (1987) Postural response of intraocular pressure in chronic open-angle glaucoma following trabeculectomy. Br. J. Ophthalmol. 71: 494-496.
116. Passo, M. S., Elliot, D. L. and Goldberg, L. (1992) Long-term effects of exercise conditioning on intraocular pressure in glaucoma suspects. J. Glaucoma 1: 39-41.
117. Passo, M. S., Goldberg, L., Elliot, D. L. and Van Buskirk, E. M. (1987) Exercise conditioning and intraocular pressure. Am. J. Ophthalmol. 103: 754-757.
118. Passo, M. S., Goldberg, L., Elliot, D. L. and Van Buskirk, E. M. (1991) Exercise training reduces intraocular pressure among subjects suspected of having glaucoma. Arch. Ophthalmol. 109: 1096-1098.
119. Passo, M. S., Palmer, E. A. and Van Buskirk, E. M. (1984) Plasma timolol in glaucoma patients. Ophthalmology 91: 1361-1363.
120. Patel, S. C. and Spaeth, G. L. (1995) Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 26: 233-236.
121. Peczon, J. D. and Grant, W. M. (1965) Glaucoma, alcohol, and intraocular pressure. Arch. Ophthalmol. 73: 495-501.
122. Pilz, A. and Comberg, D. (1961) Kreislaufanalyse des Augeninnendruckes beim valsalvaschen Versuch. Ber. Zusammenkunft Dtsch Ophthalmol. Ges. 63: 337.
123. Reader, A. L. (1982) Normal variation of intraocular pressure in vertical gaze. Ophthalmology 89: 1084-1087.
124. Rennie, I. G. (1993) Clinically important ocular reactions to systemic drug therapy. Drug Saf. 9: 196-211.
125. Rosen, D. A. and Johnston, V. C. (1959) Ocular pressure patterns in the Valsalva maneuver. Arch. Ophthalmol. 62: 810.
126. Rouhiainen, H. and Teräsirta, M. (1991) Correlation of some ocular and hematologic factors and intraocular pressure in an aged population. Acta Ophthalmol. Copenh. 69: 76-78.
127. Saunders, R. A., Helveston, E. M. and Ellis, F. D. (1981) Differential intraocular pressure in strabismus diagnosis. Ophthalmology 87: 59-70.
128. Seddon, J. M., Schwartz, B. and Flowerdew, G. (1983) Case-control study of ocular hypertension. Arch. Ophthalmol. 101: 891-894.
129. Shaivitz, S. A. (1979) Timolol and myasthenia gravis. J. Am. Med. Assoc. 242: 1611-1612.
130. Shephard, R. J., Ponsford, E., Basu, P. K. and LaBarre, R. (1978) Effects of cigarette smoking on intraocular pressure and vision. Br. J. Ophthalmol. 62: 682-687.
131. Shields, M. B. (1992) Textbook of Glaucoma, 3rd edn, pp. 515-516. Williams and Wilkins, Baltimore.
132. Shiose, Y. (1984) The aging effect on intraocular pressure in an apparently normal population. Arch. Ophthalmol. 102: 883-887.
133. Shiose, Y. and Kawase, Y. (1986) A new approach to stratified normal intraocular pressure in a general population. Am. J. Ophthalmol. 101: 714-721.
134. Siklos, P. and Henderson, R. G. (1979) Severe acidosis from acetazolamide in a diabetic patient. Curr. Med. Res. Opin. 6: 284-286.
135. Smith, R. (1991) Pressure and posture. Br. J. Ophthalmol. 75: 643.
136. Spaeth, G. L. (1967) Potassium, acetazolamide, and intraocular pressure. Arch. Ophthalmol. 78: 578-582.
137. Spaeth, G. L. (1995) 'Noncompliance' - Not a patient problem, but rather a sign of a sick doctor-patient relationship. Ophthalmic Surg. 26: 189-193.
138. Sponsel, W. E., Kaufman, P. L., strinden, T. I., DePaul, K. L., Bowes, H. N., Olander, K. W. and Barnebey, H. S. (1989) Evaluation of the Keeler Pulsair noncontact tonometer. Acta Ophthalmol. (Copenh). 67: 567-572.
139. Stewart, W. C. (1990) Clinical Practice of Glaucoma, pp. 157-158. SLACK, Thorofare, NJ.
140. Stewart, W. C. (1994) Carteolol, an ophthalmic β-adrenergic blocker with intrinsic sympathomimetic activity. J. Glaucoma 3: 339-345.
141. Stewart, W. C. (1995) The effect of lifestyle on the relative risk to develop open-angle glaucoma. Curr. Opin. Ophthalmol. 6: 3-9.
142. Stewart, W. C. (1996a) Apraclonidine. Klin Monatsbl Augenheilk in press.
143. Stewart, W. C. (1996b) Prostaglandin analogues: their usage and benifits in glaucoma treatment. Ophthal. Prac. 14: 48-55.
144. Stewart, W. C. and Castelli, W. P. (1997) Systemic side effects of topical β-adrenergic blockers. Clin. Cardiol., in press.
145. Stewart, R. H., LeBlanc, R. and Becker, B. (1970) Effects of exercise on aqueous dynamics. Am. J. Ophthalmol. 69: 245-248.
146. Stewart, W. C., Crinkley, C. M. C. and Murrell, H. P. (1994) Cigarette-smoking in normal subjects, ocular hypertensive, and chronic open-angle glaucoma patients. Am. J. Ophthalmol. 117: 267-268.
147. Stewart, W. C., Ritch, R., Shin, D. H., Lehmann, R. P., Shrader, C. E., van Buskirk, E. M. and the Apraclonidine Adjunctive Therapy Study Group (1995) The efficacy of apraclonidine as an adjunct to timolol therapy. Arch. Ophthalmol. 113: 287-292.
148. Svec, A. L. and Strosberg, A. M. (1986) Therapeutic and systemic side effects of ocular β-adrenergic antagonists in anesthetized dogs. Invest. Ophthalmol. Vis. Sci. 27: 401-405.
149. Tattersfield, A. E. (1986) Beta adrenoceptor antagonists and respiratory disease. J. Cardiovasc. Pharmacol. 8: S35-S39.
150. Tiedeman, J. S., Shields, M. B., Weber, P. A., Crow, J. W., Cocchetto, D. M., Harris, W. A. and Howes, J. F. (1981) Effect of synthetic cannabinoids on elevated intraocular pressure. Ophthalmology 88: 270-277.
151. Tong, T. G. and Ignoffo, R. J. (1972) Glaucoma. Am. Pharmac. Assoc. N.S. 12: 520-523.
152. Treister, G. and Mannor, S. (1970) Intraocular pressure and outflow facility: Effect of estrogen and combined estrogen-progestin treatment in normal human eyes. Arch. Ophthalmol. 83: 311-318.
153. Trew, D. R. and Smith, S. E. (1991) Postural studies in pulsatile ocular blood flow: I. Ocular hypertension and normotension. Br. J. Ophthalmol. 75: 66-70.
154. Urban, R. C. and Dreyer, E. B. (1993) Corticosteroid-induced glaucoma. Int. Ophthalmol. Clin. 33: 135-139.
155. Velde, T. M. and Kaiser, F. E. (1983) Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient. Arch. Int. Med. 143: 1627.
156. Watson, P. G., Stjernschantz, J. and the UK Latanoprost Study Group (1994) Intraocular pressure (IOP) reducing effect and side-effects of latanoprost and timolol. A six-month double-masked comparison. Presented at the American Academy of Ophthalmology, San Francisco, California.
157. Weber, A. K. and Price, J. (1981) Pressure differential of intraocular pressure measured between supine and sitting position. Ann. Ophthalmol. 13: 323-326.
158. Weinreb, R. N., Cook, J. and Friberg, T. R. (1984) Effect of inverted body position on intraocular pressure. Am. J. Ophthalmol. 98: 784-787.
159. Weiss, I. S. (1974) Hirsutism after chronic administration of acetazolamide. Am. J. Ophthalmol. 78: 327-328.
160. Werblin, T. P., Pollack, I. P. and Liss, R. A. (1980) Blood dyscrasias in patients using methazolamide (Neptazane) for glaucoma. Ophthalmology 87: 350-354.
161. West, J. and Longstaff, S. (1990) Topical timolol and serum lipoproteins. Br. J. Ophthalmol. 74: 663-664.
162. Williams, B. I. and Peart, W. S. (1978) Effect of posture on the intraocular pressure of patients with retinal vein obstruction. Br. J. Ophthalmol. 62: 688-693.
163. Wilson, M. R., Hertzmark, E., Walker, A. M., Childs-Shaw, K. and Epstein, D. L. (1987) A case-control study of risk factors in open angle glaucoma. Arch. Ophthalmol. 105: 1066-1071.
164. Wilson, R. P., Spaeth, G. L. and Poryzees, E. (1980) The place of timolol in the practice of ophthalmology. Ophthalmology 87: 451-454.
165. Winfield, A. J., Jessiman, D., Williams, A. and Esakowitz, L. (1990) A study of the causes of non-compliance by patients prescribed eyedrops. Br. J. Ophthalmol. 74: 477-480.
166. Wisch, N., Fischbein, F. I., Siegel, R., Glass, J. L. and Leopold, I. (1973) Aplastic anemia resulting from the use of carbonic anhydrase inhibitors. Am. J. Ophthalmol. 75: 130-132.
167. Yamabayashi, S., Aguilar, R. N., Hosoda, M. and Tsukahara, S. (1991) Postural change of intraocular and blood pressures in ocular hypertension and low tension glaucoma. Br. J. Ophthalmol. 75: 652-655.
168. Zimmerman, T. J., Baumann, J. D. and Hetherington, J. (1983) Side effects of timolol. Surv. Ophthalmol. 28: 243-249.